Your browser doesn't support javascript.
loading
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
Karrar, Omer; Abdelmagid, Maymona; Rana, Masooma; Iftikhar, Moazah; McCullough, Kristen; Al-Kali, Aref; Alkhateeb, Hassan B; Begna, Kebede H; Elliott, Michelle A; Mangaonkar, Abhishek; Saliba, Antoine; Hefazi Torghabeh, Mehrdad; Litzow, Mark R; Hogan, William; Shah, Mithun; Patnaik, Mrinal M; Pardanani, Animesh; Badar, Talha; Murthy, Hemant; Foran, James; Palmer, Jeanne; Sproat, Lisa; Khera, Nandita; Arana Yi, Cecilia; Tefferi, Ayalew; Gangat, Naseema.
Afiliação
  • Karrar O; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Abdelmagid M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Rana M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Iftikhar M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • McCullough K; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Alkhateeb HB; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Elliott MA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Mangaonkar A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Saliba A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Hefazi Torghabeh M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Hogan W; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Shah M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Badar T; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Murthy H; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Foran J; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Palmer J; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Sproat L; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Khera N; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Arana Yi C; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 99(2): E63-E66, 2024 02.
Article em En | MEDLINE | ID: mdl-38100217
ABSTRACT
Overall survival and response rates of 270 patients with newly diagnosed acute myeloid leukemia receiving venetoclax (Ven) plus hypomethylating agent, stratified by Ven dosing schedule (Cycle 1 Ven 14 vs. 21 vs. 28 days).
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Humans Idioma: En Revista: Am J Hematol / Am. j. hematol / American journal of hematology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Humans Idioma: En Revista: Am J Hematol / Am. j. hematol / American journal of hematology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos